Search
for
Sort by
Research 31–60 of 431
- Chemotherapy-induced toxicity—a secondary effect caused by released DNA?
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Retiform Purpura Caused by the Use of Cocaine, That Was Probably Adulterated with Levamisole
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Pseudoglucagonoma Syndrome Following Frey’s Surgery: A Case Report of a Rare Presentation
- Referee report. For: Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania [version 1; peer review: 1 approved, 1 approved with reservations]
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Complications associated with oncological therapy - how to minimize?
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Abstracts from the ASA 40thAnnual Meeting
- 420 Severe thiopurine-induced myelotoxicity and hair loss in Japanese patients with NUDT15 gene variant: A retrospective case-control study
- Flow Cytometry In The Differential Diagnosıs Of Neutropenic Patients
- Docetaxel.
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex)
- Multiple iridociliary cysts in patients with mucopolysaccharidoses
- Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
- Bilateral non-specific orbital inflammation (orbital "pseudotumour"), posterior scleritis, and anterior uveitis associated with hypothyroidism in a child
- Acquired ocular toxoplasmosis in pregnancy
- Bilateral anterior uveitis as a presenting manifestation of sarcoidosis and syphilis
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System